| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.162.054 |
| Chemical and physical data | |
| Formula | C23H24Cl2N2O3 |
| Molar mass | 447.36 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
GW-405,833 (L-768,242) is a drug that acts as a potent and selectivepartial agonist for thecannabinoid receptor subtypeCB2, with anEC50 of 0.65 nM and selectivity of around 1200x for CB2 overCB1 receptors.[1][2] Animal studies have shown it to possessantiinflammatory and anti-hyperalgesic effects at low doses, followed byataxia andanalgesic effects when the dose is increased.[3][4] Selective CB2 agonist drugs such as GW-405,833 are hoped to be particularly useful in the treatment ofallodynia andneuropathic pain for which current treatment options are often inadequate.[5][6]
Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |